首页> 外文期刊>Journal of the Siena Academy of Sciences >VESCICO-URETERAL REFLUX: ENDOSCOPIC TREATMENT, MANAGEMENT AND LONG-TERM FOLLOW-UP
【24h】

VESCICO-URETERAL REFLUX: ENDOSCOPIC TREATMENT, MANAGEMENT AND LONG-TERM FOLLOW-UP

机译:输尿管反流:内镜治疗,管理和长期随访

获取原文
       

摘要

Introduction. Vescicoureteral reflux (VUR) is a dynamic event in which there is a retrograde passage of urine from the bladder to the ureters. It is the most common urological disease in the childhood and it manifests with recurrent urinary tract infections (UTI). The therapeutic strategy provides an antibiotic prophylaxis, invasive surgery (Cohen reimplantation) and minimally invasive surgery (endoscopic subureteral injection). Recently, Endoscopic Subureteral Injection with Deflux became the treat- ment of choice. The purpose of this work was to conduce a retrospective study of our patients with VUR to evaluate the role of endoscopic technique (Deflux and Macroplastique) in the treatment. Materials and Methods. Forty two patients with VUR were treated by us in 65 refluxing units. Twenty were males (47.6%) and 22 (52.4%) females. Sex, age of infiltration, presence of associated diseases, unilaterality and bilaterality, side of pres- entation of VUR and substance used for injection were considered. The follow-up study included urine cultures and periodic renal ultrasound. The mintional cistouretrography was performed after 12 months. The results were statistically evaluated with the "Wilcoxson test”, comparing data of patients treated with Deflux and Macroplastique. results. Refluxing ureters underwent endoscopic treatment by submeatal injection were 65, 4.6% with VUR grade I, 12.3% grade II, 43% grade III, 29.23% grade IV and 10.87% gradeV. In 19 patients, amounting to 45.2%, this was a unilateral VUR (84.2% left, 15.78% right) and in 23 patients, equal to 54.76%, a bilateral VUR. Thirdy eight per cent of these patients had associated diseases. At the first follow-up, the cure rate was 81.53%. At the second follow-up, the cure rate, including the 9 children re-infiltrated, was 89.23%. Four patients underwent a further infiltration, so as at the third follow-up, the overall cure rate was 93.84%. In only one patient with bilateral VUR grade IV, it was necessary to perform Cohen ureteral reimplan- tation due to the persistence of VUR after 2 endoscopic infiltration. In another one, due to the clinical severity and the per- sisting of VUR after two endoscopic infiltration, we decided to plan the bilateral reimplant according to Cohen. We have not been demonstrated significant differences based on gender, age of infiltration and the substance used, were not observed. Conclusions. At the moment, ours patients have a regular weight-height growth and they don’t have urinary tract infection or vescicoureteral reflux. The sub-meatal infiltration is a simple, repeatable and reliable techinique whereby results are imme- diate and safe in most cases. For this reason, we conclude that the submeatal infiltration represents the first-line treatment in patients with vescicoureteral reflux.
机译:介绍。膀胱输尿管反流(VUR)是一种动态事件,尿液从膀胱逆行进入输尿管。它是儿童时期最常见的泌尿科疾病,表现为尿路反复感染(UTI)。该治疗策略提供了抗生素预防,侵入性手术(Cohen再植)和微创手术(内窥镜输尿管下注射)。最近,内镜下输注排尿镜成为首选治​​疗方法。这项工作的目的是对我们的VUR患者进行回顾性研究,以评估内镜技术(Deflux和Macroplastique)在治疗中的作用。材料和方法。我们对65例回流患者进行了42例VUR患者的治疗。男性为20名(47.6%),女性为22名(52.4%)。考虑了性别,浸润年龄,相关疾病的存在,单方面和双侧性,VUR的表现和注射用物质。后续研究包括尿培养和定期的肾脏超声检查。十二个月后进行了小脑尿道造影。用“ Wilcoxson检验”对结果进行统计学评估,比较接受去甲流和Macroplastique治疗的患者的数据,经皮下注射内窥镜治疗的回流输尿管分别为65、4.6%(VUR等级为I,12.3%等级为II,43%等级) III级,IV级为29.23%,V级为10.87%。在19例患者中,占45.2%,这是单侧VUR(左84.2%,右15.78%),在23例患者中,即54.76%是双侧VUR。这些患者中有10%患有相关疾病,第一次随访治愈率为81.53%;第二次随访治愈率为89.23%,其中包括9例再次渗入的儿童,其中4例接受了进一步的浸润,因此在第三次随访中,总治愈率为93.84%,只有1例双侧VUR分级为IV级的患者,由于2次内镜下浸润后VUR的持续存在,因此有必要进行Cohen输尿管再植在另一种中,由于临床严重性和如果在两次内镜下浸润后仍保留VUR,我们决定根据Cohen计划进行双侧再植。没有观察到基于性别,渗透年龄和所用物质的明显差异。结论。目前,我们的患者的体重正常增长,并且没有尿路感染或胸膜腔返流。副肉浸润是一种简单,可重复且可靠的技术,在大多数情况下,结果即刻且安全。出于这个原因,我们得出结论,肉囊下浸润是膀胱膀胱返流患者的一线治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号